223 related articles for article (PubMed ID: 25382690)
1. Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.
Foster KA; Ares WJ; Pollack IF; Jakacki RI
Pediatr Blood Cancer; 2015 Feb; 62(2):240-245. PubMed ID: 25382690
[TBL] [Abstract][Full Text] [Related]
2. Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature.
Nguyen TK; Perry J; Sundaram ANE; Detsky J; Maralani PJ; Calabrese E; Das S; Sahgal A
J Neurooncol; 2019 Jul; 143(3):475-481. PubMed ID: 31054097
[TBL] [Abstract][Full Text] [Related]
3. Pseudoprogression of low-grade gliomas after radiotherapy.
Naftel RP; Pollack IF; Zuccoli G; Deutsch M; Jakacki RI
Pediatr Blood Cancer; 2015 Jan; 62(1):35-9. PubMed ID: 25213668
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas.
Hwang EI; Jakacki RI; Fisher MJ; Kilburn LB; Horn M; Vezina G; Rood BR; Packer RJ
Pediatr Blood Cancer; 2013 May; 60(5):776-82. PubMed ID: 22976922
[TBL] [Abstract][Full Text] [Related]
5. Severe Radiation Necrosis Successfully Treated With Bevacizumab in an Infant with Low-Grade Glioma and Tumor-Associated Intractable Trigeminal Neuralgia.
Pillay Smiley N; Alden T; Hartsell W; Fangusaro J
Pediatr Blood Cancer; 2016 Sep; 63(9):1671-3. PubMed ID: 27187113
[TBL] [Abstract][Full Text] [Related]
6. Single-shot bevacizumab for cerebral radiation injury.
Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
[TBL] [Abstract][Full Text] [Related]
7. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
Lubelski D; Abdullah KG; Weil RJ; Marko NF
J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
[TBL] [Abstract][Full Text] [Related]
9. Decreased tumor apparent diffusion coefficient correlates with objective response of pediatric low-grade glioma to bevacizumab.
Hsu CH; Lober RM; Li MD; Partap S; Murphy PA; Barnes PD; Fisher PG; Yeom KW
J Neurooncol; 2015 May; 122(3):491-6. PubMed ID: 25758812
[TBL] [Abstract][Full Text] [Related]
10. Single-agent bevacizumab in the treatment of recurrent or refractory pediatric low-grade glioma: A single institutional experience.
Gorsi HS; Khanna PC; Tumblin M; Yeh-Nayre L; Milburn M; Elster JD; Crawford JR
Pediatr Blood Cancer; 2018 Sep; 65(9):e27234. PubMed ID: 29750399
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
Liu AK; Macy ME; Foreman NK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
[TBL] [Abstract][Full Text] [Related]
13. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
14. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy.
Huynh-Le MP; Walker AJ; Burger PC; Jallo GI; Cohen KJ; Wharam MD; Terezakis SA
Childs Nerv Syst; 2016 Aug; 32(8):1425-30. PubMed ID: 27179530
[TBL] [Abstract][Full Text] [Related]
15. Low-grade gliomas in children: tumor volume response to radiation.
Fisher BJ; Bauman GS; Leighton CE; Stitt L; Cairncross JG; Macdonald DR
J Neurosurg; 1998 Jun; 88(6):969-74. PubMed ID: 9609290
[TBL] [Abstract][Full Text] [Related]
16. Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.
van West SE; de Bruin HG; van de Langerijt B; Swaak-Kragten AT; van den Bent MJ; Taal W
Neuro Oncol; 2017 May; 19(5):719-725. PubMed ID: 28453748
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy.
Ludmir EB; Mahajan A; Paulino AC; Jones JY; Ketonen LM; Su JM; Grosshans DR; McAleer MF; McGovern SL; Lassen-Ramshad YA; Adesina AM; Dauser RC; Weinberg JS; Chintagumpala MM
Neuro Oncol; 2019 May; 21(5):686-695. PubMed ID: 30753704
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of centrally located low-grade glioma in children.
Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M
Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab in late-onset radiation-induced myelopathy.
Psimaras D; Tafani C; Ducray F; Leclercq D; Feuvret L; Delattre JY; Ricard D
Neurology; 2016 Feb; 86(5):454-7. PubMed ID: 26740673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]